Research and Development

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …

Being a firm that specialises in cancer drugs, Celgene UK is no stranger to England’s notoriously rigorous approach to expensive …

US drug development firm Vermillion has appointed Veronica Jordan and David Schreiber to the company’s board of directors.  Dr Veronica …

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …

US developer of injectable drugs Unilife has looked to Intel to appoint a marketing and communications veteran in Kevin Sellers. …

Antibiotic-resistant bacteria will kill an extra 10 million people a year by 2050 if the problem is not tackled soon, …

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …

Marketing communications agency Liberation Unlimited has appointed Kim Lemon to head its operations. Since the UK-based comms firm joined the …

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …